NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
Locally advanced, unresectable non-small-cell lung cancer (NSCLC)
(Stage III) with a PD-L1-expression of ≥ 1%
1 total trials1 recruiting
Filter these 1 trials by phase, country, sponsor and more.